Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe COVID-19 Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04288102
What this trial is testing

Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19)

Who this might be right for
Corona Virus Disease 2019(COVID-19)
Beijing 302 Hospital 100
Testing effectiveness (Phase 2)Study completedNCT04311177
What this trial is testing

Losartan for Patients With COVID-19 Not Requiring Hospitalization

Who this might be right for
Corona Virus InfectionAcute Respiratory Distress SyndromeSARS-CoV Infection
University of Minnesota 117
Testing effectiveness (Phase 2)Study completedNCT04347239
What this trial is testing

Evaluate the Efficacy & Safety of Leronlimab in Patients With Severe or Critical COVID-19

Who this might be right for
Coronavirus Disease 2019
CytoDyn, Inc. 484
Testing effectiveness (Phase 2)Ended earlyNCT04771000
What this trial is testing

Micro Dose Ambrisentan in Hospitalized Patients With Respiratory Insufficiency Due to COVID-19

Who this might be right for
Covid19Hypoxemia
Noorik Biopharmaceuticals AG 88
Not applicableStudy completedNCT04460664
What this trial is testing

Coagulation Changes Associated With COVID-19 Infection

Who this might be right for
COVIDDisseminated Intravascular CoagulationCoagulation Disorder
HemoSonics LLC 15
Not applicableUnknownNCT04617119
What this trial is testing

The Effects of Multi-modality Physiotherapy in Delaying or Preventing COVID-19 Patient From Admitting to ICU

Who this might be right for
Covid19Severe Systemic Illness Respiratory Muscle Fatigue
DR. JASSIM ALGHAITH 38
Testing effectiveness (Phase 2)Ended earlyNCT04370834
What this trial is testing

Tocilizumab for Patients With Cancer and COVID-19 Disease

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmPneumonia+3 more
National Cancer Institute (NCI) 1
Post-approval studies (Phase 4)UnknownNCT04350671
What this trial is testing

Interferon Beta 1a in Hospitalized COVID-19 Patients

Who this might be right for
COVID-19
Shahid Beheshti University of Medical Sciences 40
Not applicableStudy completedNCT04371471
What this trial is testing

Pandemic Triage Score in Patients With Known or Suspected Severe Acute Respiratory Syndrome (SARS) CoronaVirus (CoV) 2 Infection

Who this might be right for
SARS-CoV-2 Acute Respiratory DiseaseCovid19
Groupe Hospitalier de la Rochelle Ré Aunis 91
Not applicableNo Longer AvailableNCT04337359
What this trial is testing

Ruxolitinib Managed Access Program (MAP) for Patients Diagnosed With Severe/Very Severe COVID-19 Illness

Who this might be right for
Severe/Very Severe COVID-19 Illness
Novartis Pharmaceuticals
Large-scale testing (Phase 3)WithdrawnNCT04372082
What this trial is testing

Hydroxychloroquine or Diltiazem-Niclosamide for the Treatment of COVID-19

Who this might be right for
Sars-CoV2
University Hospital, Lille
Testing effectiveness (Phase 2)Study completedNCT04745442
What this trial is testing

Pilot Study of Antithrombin as Prophylaxis of Acute Respiratory Distress Syndrome in Patients With COVID-19

Who this might be right for
Covid19Severe Acute Respiratory SyndromeDistress Respiratory Syndrome
Maimónides Biomedical Research Institute of Córdoba 48
Post-approval studies (Phase 4)Study completedNCT04326920
What this trial is testing

Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC)

Who this might be right for
COVID-19
University Hospital, Ghent 87
Not applicableStudy completedNCT06402279
What this trial is testing

Hemoperfusion Efferon СT for the Extremely Severe Form of COVID-19

Who this might be right for
COVID-19
Efferon JSC 130
Testing effectiveness (Phase 2)UnknownNCT05200754
What this trial is testing

Trial With or Without Infusion of SARS-CoV-2 Antibody Containing Plasma in High-Risk Patients With COVID-19

Who this might be right for
SARS-CoV-2 Infection
Carsten Müller-Tidow 174
Not applicableUnknownNCT05670275
What this trial is testing

Microecology and Host Immunity in Patients With Severe COVID-19 Infection

Who this might be right for
Microbiome,Immune Function, Critically Ill
Chinese PLA General Hospital 200
Testing effectiveness (Phase 2)Ended earlyNCT04414631
What this trial is testing

Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19

Who this might be right for
Coronavirus Infections
University Hospital, Basel, Switzerland 80
Large-scale testing (Phase 3)Study completedNCT04546581
What this trial is testing

Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)

Who this might be right for
COVIDCOVID-19SARS-CoV-2+1 more
University of Minnesota 593
Not applicableUnknownNCT05803395
What this trial is testing

Incidence of Severe COVID-19 Infection in Patients With CLL or B-NHL Who Received Pre-exposure Prophylaxis With Tixagevimab and Cilgavimab in Italy.

Who this might be right for
Chronic Lymphocytic LeukemiaIndolent B-Cell Non-Hodgkin LymphomaCOVID-19
Gruppo Italiano Malattie EMatologiche dell'Adulto 954
Large-scale testing (Phase 3)UnknownNCT05445934
What this trial is testing

Evaluate the Efficacy and Safety of FB2001 in Hospitalized Patients With Moderate to Severe COVID-19 (BRIGHT Study)

Who this might be right for
COVID-19
Frontier Biotechnologies Inc. 1,188
Next Page